PARR MCKNIGHT WEALTH MANAGEMENT GROUP, LLC
Position in ABBV — AbbVie Inc.
CIK 2026926
MINNEAPOLIS, MN
Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,947,979
+$442,911 QoQ
Shares Held
15,689
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#1,462
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARR MCKNIGHT WEALTH MANAGEMENT GROUP, LLC holds $42,908,567 across 9 Drug Manufacturers - General names. ABBV ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
52,427 | $13,314,885 | |
| 2 | LLY |
ELI LILLY & Co
|
7,918 | $9,497,087 | |
| 3 | AMGN |
Amgen Inc
|
14,946 | $5,412,245 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
15,689 | $3,947,979 | |
| 5 | AZN |
Astrazeneca PLC
|
20,406 | $3,869,385 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,951 | $3,334,703 | |
| 7 | NVS |
Novartis AG
|
18,651 | $2,922,984 | |
| 8 | NVO |
Novo Nordisk A S
|
7,120 | $341,332 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,947,979 | 15,689 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,505,068 | 16,116 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,124,902 | 26,806 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,548,645 | 28,283 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,331,377 | 28,722 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,019,300 | 28,729 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,178,533 | 29,142 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||